Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
Issue Information
- Pages: i-iii
- First Published: 30 January 2024
On the Cover: “Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease” Kalveram et al 27–35
EDITORIAL
INVITED COMMENTARY
EXPERIENCE FROM THE FIELD
Medical Education
Weighing the scales: Taking a balanced approach to diet therapies in pediatric inflammatory bowel disease
- Pages: 4-7
- First Published: 11 December 2023
REVIEW ARTICLE
The impact of integrating behavioral health services into pediatric subspecialty care: A systematic review
- Pages: 8-16
- First Published: 27 December 2023
ORIGINAL ARTICLES
Hepatology
Budd-Chiari syndrome in children: Radiological intervention and role of shear wave elastography in monitoring response
- Pages: 17-26
- First Published: 06 December 2023
Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease
- Pages: 27-35
- First Published: 29 December 2023
Gastroenterology
Clinical relevance of inflammation on rectal biopsy for Hirschsprung disease: An outcomes analysis
- Pages: 36-42
- First Published: 11 December 2023
Intestinal dysbiosis and inflammation in children with repaired esophageal atresia
- Pages: 43-51
- First Published: 10 December 2023
Brain imaging abnormalities in children with dysphagia with aspiration: A retrospective study
- Pages: 52-56
- First Published: 10 December 2023
Gastroenterology: Inflammatory Bowel Disease
Effectiveness of strategies to suppress antibodies to infliximab in pediatric inflammatory bowel disease
- Pages: 57-67
- First Published: 05 December 2023

The development of antibodies to infliximab (ATIs) commonly causes a loss of response in children with inflammatory bowel disease. This retrospective cohort study showed that treatment escalation with infliximab (dose optimization and/or adding an immunomodulator) seems to be an effective strategy to suppress ATIs in patients with low ATI titers (≤30 AU/mL). For high ATI titers, this strategy could also be considered before switching.
Intraperitoneal insufflation of carbon dioxide rescues intestinal damage in an experimental murine model of colitis
- Pages: 68-76
- First Published: 10 December 2023
The contributions of clinical disease activity, functional disability, and illness intrusiveness to depressive symptoms in pediatric inflammatory bowel disease
- Pages: 77-84
- First Published: 10 December 2023
Trajectory of body mass index and obesity in children with Crohn's disease compared to healthy children
- Pages: 85-94
- First Published: 10 December 2023
Identifying risk factors of anti-TNF induced skin lesions and other adverse events in paediatric patients with inflammatory bowel disease
- Pages: 95-104
- First Published: 10 December 2023
Gastroenterology: Celiac Disease
Health-related quality of life in children with coeliac disease and in their families: A long-term follow-up study
- Pages: 105-112
- First Published: 11 December 2023
Nutrition
Music therapy and weight gain in preterm infants: Secondary analysis of the randomized controlled LongSTEP trial
- Pages: 113-121
- First Published: 10 December 2023
POSITION STATEMENTS AND PRACTICE GUIDELINES
Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis
- Pages: 122-152
- First Published: 30 January 2024
Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper
- Pages: 153-165
- First Published: 30 January 2024
CASE IMAGES
Investigating an Incidental Finding on Abdominal CT Scan in a 7-Year-Old Child
- Page: 167
- First Published: 30 January 2024